RxDoctor Payments Data

Derek Shia, MD

Adult Reconstructive Orthopaedic Surgery · Hamden, CTNPI 1861600165

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,500 of the $7,497 with a category attached, or 60.0%. Depuy Synthes Products, Inc. accounts for 60.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $5,532 and has fallen 93.1% since, to $382 in 2025.

$7,497in general payments, 2019–2025

Across 52 payments — averaging $144.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$5K
  • Johnson & Johnson$889
  • Medacta USA, Inc.$747
  • Medical Device Business Services, Inc.$591
  • Smith+Nephew$373
  • Amgen$162
  • plus $235 from 3 others

What the payments were for

  • Consulting fees$4,50060%
  • Travel & lodging$1,09815%
  • Food & beverage$1,89925%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Connecticutto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$169,759
Medicare patients
297
Services billed
2,037

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clindamycin-Benzoyl PeroxideClindamycin Phos/Benzoyl Perox15$1,037
Amoxicillin-Clavulanate Pot ErAmoxicillin/Potassium Clav41$877
Naproxen80$472
Celecoxib26$460
Oxycodone Hcl88$443
Gabapentin97$344
Methylprednisolone52$287
Ondansetron Hcl78$178
Meloxicam86$159
Famotidine14$78
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$77
Clindamycin Hcl14$50
Tramadol Hcl25$50
Amoxicillin13$6

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Hamden

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →